Clinical Cell Culture Limited
Perth ASX-listed company Clinical Cell Culture (C3) has been awarded a $152,000 grant from AusIndustry’s Biotechnology Innovation scheme.
C3 says the grant will be used to research methods for stimulating skin cells to multiply without the use of any material taken from any source other than the patient’s own body.
This process will be developed using blood harvested from the patient’s wounds.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.